BRISTOPEN Side Effects

6936893-3 | Eosinophilia, Kaposi's Varicelliform Eruption
on Aug 13, 2010 Male patient from FRANCE , weighting 13.23 lb, was diagnosed with antibiotic prophylaxis, superinfection, pneumococcal immunisation and was treated with Bristopen (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, kaposi's varicelliform eruption. Bristopen dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (1df=100 Mg/12.5 Mg/ml(amoxicillin/clavulanic Acid) 1 Intake Per Kg Three Times Daily) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), HELICIDINE (View Helicidine Review and Helicidine Label ), UVEDOSE (View Uvedose Review and Uvedose Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), NETROMYCIN (View Netromycin Review and Netromycin Label ), PREVENAR (Second Dose) (View Prevenar Review and Prevenar Label ), POLARAMINE (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

4844939-1 | Alanine Aminotransferase Increased, Hepatitis Cholestatic
Patient was taking Bristopen (View Usage). Patient had the following side effects: alanine aminotransferase increased, hepatitis cholestatic on Nov 23, 2005 from FRANCE Additional patient health information: Female patient , 52 years of age, was diagnosed with erysipelas and. Bristopen dosage: . During the same period patient was treated with ENDOTELON (View Endotelon Review and Endotelon Label ), NOCTRAN (View Noctran Review and Noctran Label ), ATHYMIL (View Athymil Review and Athymil Label ), ADVIL (View Advil Review and Advil Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.

4833033-1 | Dermatitis Bullous, Face Oedema, Rash Erythematous
Adverse event was reported on Nov 09, 2005 by a Female patient taking Bristopen (View Usage) (Dosage: ) . Location: FRANCE , 79 years of age, After Bristopen was administered, patient had the following side effects: dermatitis bullous, face oedema, rash erythematous. During the same period patient was treated with PYOSTACINE (View Pyostacine Review and Pyostacine Label ), VANCOMYCIN (Doses: 2) (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (Dose: 2) (View Gentamicin Review and Gentamicin Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ZESTRIL (View Zestril Review and Zestril Label ), TANGANIL (View Tanganil Review and Tanganil Label ), LASILIX (View Lasilix Review and Lasilix Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

4797415-9 | Thrombocytopenia
on Sep 12, 2005 Male patient from FRANCE , 78 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Bristopen (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Bristopen dosage: . During the same period patient was treated with CALPARINE (View Calparine Review and Calparine Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), MOPRAL (View Mopral Review and Mopral Label ), CALCIDIA (Dosage Form = Sachets) (View Calcidia Review and Calcidia Label ), PROZAC (View Prozac Review and Prozac Label ), LASILIX (View Lasilix Review and Lasilix Label ). Patient was hospitalized.


4791123-6 | Leukopenia, Pancytopenia, Thrombocytopenia
on Sep 27, 2005 Male patient from FRANCE , 62 years of age, weighting 200.6 lb, was treated with Bristopen (View Usage). Patient had the following side effects: leukopenia, pancytopenia, thrombocytopenia. Bristopen dosage: . During the same period patient was treated with BRISTOPEN CAPS 500 MG (View Bristopen Caps 500 Mg Review and Bristopen Caps 500 Mg Label ), PREVISCAN (Dosage Alternating With 1/2 Tablet/d For Inr Ranging From 3 To 4.) (View Previscan Review and Previscan Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), ZESTRIL (View Zestril Review and Zestril Label ), LASILIX (40 Mg In The Morning And 20 Mg At Lunch) (View Lasilix Review and Lasilix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

4648582-9 | Dermatitis Bullous, Henoch-schonlein Purpura
Patient was taking Bristopen (View Usage). After Bristopen was administered, patient had the following side effects: dermatitis bullous, henoch-schonlein purpura on Apr 18, 2005 from Additional patient health information: Female patient , 90 years of age, was diagnosed with localised infection and. Bristopen dosage: . During the same period patient was treated with DAFALGAN (View Dafalgan Review and Dafalgan Label ), HEXAMIDINE (View Hexamidine Review and Hexamidine Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), APROVEL (View Aprovel Review and Aprovel Label ), DAFLON (View Daflon Review and Daflon Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), DEROXAT (View Deroxat Review and Deroxat Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

4621865-4 | Ascites, Concomitant Disease Aggravated, Hepatic Cirrhosis, Hepatic Enzyme Increased, Hepatic Failure, Hyperbilirubinaemia, Hypersplenism, Jaundice, Nervous System Disorder
Adverse event was reported on Feb 23, 2005 by a Male patient taking Bristopen (View Usage) (Dosage: ) was diagnosed with osteoarthritis (What is osteoarthritis?), lipid metabolism disorder, oedema, ascites and. Location: , 61 years of age, Patient experienced the following unwanted or unexpected effects: ascites, concomitant disease aggravated, hepatic cirrhosis, hepatic enzyme increased, hepatic failure, hyperbilirubinaemia, hypersplenism, jaundice (What is jaundice?), nervous system disorder. During the same period patient was treated with VASTEN TABS (View Vasten Tabs Review and Vasten Tabs Label ), ORBENINE (View Orbenine Review and Orbenine Label ), ALDACTONE (Increased To 150 Mg/day) (View Aldactone Review and Aldactone Label ), LASIX (Increased To 40 Mg/day) (View Lasix Review and Lasix Label ), KEPPRA (View Keppra Review and Keppra Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

4612669-7 | Ascites, Hepatic Cirrhosis, Hepatic Enzyme Increased, Hepatic Failure, Hyperbilirubinaemia, Hypersplenism, Jaundice, Neurological Examination Abnormal, Oedema
on Feb 23, 2005 Male patient from , 61 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), oedema, ascites and was treated with Bristopen (View Usage). Patient had the following side effects: ascites, hepatic cirrhosis, hepatic enzyme increased, hepatic failure, hyperbilirubinaemia, hypersplenism, jaundice (What is jaundice?), neurological examination abnormal, oedema. Bristopen dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), ALDACTONE (Increased To 150 Mg/day) (View Aldactone Review and Aldactone Label ), LASIX (Increased To 40 Mg/day) (View Lasix Review and Lasix Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

4601659-6 | Alanine Aminotransferase Increased, Ascites, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased, Hyperbilirubinaemia, Hypersplenism, Jaundice
on Feb 23, 2005 Male patient from , 61 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?), oedema, ascites and was treated with Bristopen (View Usage). After Bristopen was administered, patient had the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic enzyme increased, hyperbilirubinaemia, hypersplenism, jaundice (What is jaundice?). Bristopen dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ORBENIN CAP (View Orbenin Cap Review and Orbenin Cap Label ), ALDACTONE (Increased To 150 Mg/day) (View Aldactone Review and Aldactone Label ), LASIX (Increased To 40 Mg/day) (View Lasix Review and Lasix Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.